Stramonium

Quick links to important sections

Stramonium

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Stramonium

Overview of Stramonium

Stramonium, derived from the plant Datura stramonium, is a botanical substance historically utilized in various traditional medicinal practices. Commonly known by names such as thorn apple, jimsonweed, or devil's snare, it belongs to the Solanaceae (nightshade) family. The plant is characterized by its white or violet trumpet-shaped flowers and prickly seed capsules.

Botanical Characteristics

Datura stramonium is an annual herb that grows in temperate and tropical regions worldwide. It contains several naturally occurring alkaloids, primarily hyoscyamine, scopolamine, and atropine. These compounds are concentrated in the leaves, flowers, and seeds of the plant. In a pharmaceutical and homeopathic context, these components are processed to create specific preparations.

Historical and Traditional Use

Historically, Stramonium has been recognized for its anticholinergic properties. In various traditional systems of medicine, it was explored for its effects on the respiratory system and the central nervous system. Modern applications, particularly within homeopathy, involve highly diluted preparations of the substance. These preparations are developed based on the principle of using botanical extracts to address specific symptom profiles related to emotional or physical states.

What side effects are possible with Stramonium?

Possible Side Effects and Safety Information

The safety profile of Stramonium, a source of potent tropane alkaloids, is characterized by the systemic effects of strong anticholinergic activity, which carries a high risk of toxicity. The officially documented adverse reactions are categorized by the physiological systems they affect, primarily involving the nervous, cardiovascular, and autonomic systems.

Expected adverse reactions, often classified as common for its active components, include dry mouth, blurred vision, tachycardia (rapid heartbeat), constipation, and urinary retention. Central nervous system effects can include dizziness, drowsiness, and, at toxic levels, severe manifestations such as confusion, agitation, and delirium.

Documented Serious Safety Outcomes

Regulatory sources explicitly document that the ingestion of Stramonium may lead to serious adverse outcomes, including respiratory distress and failure, seizures or convulsions, coma, and even death. Other serious risks include the precipitation of acute glaucoma and severe hyperthermia resulting from the inhibition of sweating.

Population-Specific Constraints

The risk profile is considered heightened for certain populations. Children are documented as being more sensitive to the toxic effects, and older adults have an increased risk of severe anticholinergic effects, including CNS disturbances and urinary retention. Furthermore, the substance is classified as unsafe for use during pregnancy and breast-feeding. Safety is also constrained by contraindications in patients with conditions like untreated narrow-angle glaucoma and urinary retention.

Overdose and Emergency Response

Overdose and When to Seek Help

Stramonium overdose is characterized by severe manifestations of anticholinergic toxicity, as documented in regulatory prescribing information for its active components. An overdose may lead to marked central nervous system (CNS) effects, including severe excitement, delirium, seizures, and potentially coma.

Peripheral signs officially documented include pronounced mydriasis (dilated pupils), hot, dry skin, severe dryness of the mouth and throat, and tachycardia (fast heart rate). Life-threatening outcomes such as circulatory collapse and respiratory failure are officially listed complications requiring immediate attention.

Immediate medical attention must be sought upon recognizing any severe manifestations. Officially described management may include the administration of the documented antidote, Physostigmine, for reversal of central anticholinergic toxicity. Supportive measures, such as gastric lavage and physical cooling (e.g., hypothermic blanket) for documented hyperthermia, are regulatory procedures.

Special considerations are noted for vulnerable populations: pediatric patients are documented as more susceptible to the toxic effects, particularly the risk of rapid, dangerous fever. Elderly patients may experience confusion and agitation at lower dosages.

Therapeutic Uses of Stramonium

What Stramonium Treats: Main Uses and Benefits

Stramonium is applied across domains where additional symptomatic support is needed for symptoms related to heightened physiological activity. Its active components are commonly used in contexts marked by increased discomfort or tension. It is historically relevant for use in situations involving certain distressing symptoms associated with bronchial spasms and airway constriction, visceral pain and cramping, and motion-induced nausea and vomiting.


Symptomatic Support for Spasmodic Distress

The substance is commonly used to help with symptoms related to physical discomfort, particularly across conditions presenting with acute episodes where physical discomfort is a primary concern. This assists with managing symptoms related to episodic or fluctuating manifestations, such as colicky pain. It is relevant for easing difficulty breathing by easing symptoms that create noticeable physiological strain, particularly those involving constricted airways.


Quick Fact: Relief for Acute Discomfort
Primary Focus Symptoms that interfere with daily functioning
Key Symptom Difficulty breathing, colicky abdominal pain
Patient Benefit Contributes to improved comfort during heightened symptoms

Addressing Systemic Imbalances

Stramonium is considered relevant for easing symptoms of increased neurological or muscular activity, such as motor rigidity and tremor. Furthermore, it contributes to improved comfort by assisting with managing symptoms related to systemic imbalance, such as nausea and vomiting, often used during phases when these symptoms become more noticeable due to motion.

Regulatory References

  1. NIH MedlinePlus overview of Hyoscyamine uses

Eligibility and Restrictions for Use

Who Can and Cannot Use Stramonium?

The raw botanical product, Stramonium (Datura stramonium), is widely classified by government sources as unsafe and poisonous for self-medication. The specific eligibility rules below are derived from the official regulatory labeling for its purified active component, Hyoscyamine sulfate, which is an anticholinergic agent.


Contraindications and Restrictions

Category Regulatory Status
Absolute Contraindications Use is prohibited for patients with glaucoma, myasthenia gravis, obstructive diseases of the GI or urinary tract (e.g., prostatic hypertrophy, paralytic ileus), severe ulcerative colitis, and myocardial ischemia or unstable cardiovascular status in acute hemorrhage.
Pediatric Use The drug is not recommended for use in children under twelve (12) years of age.
Maternal Status Use is conditional during pregnancy (Category C), administered only if clearly needed. The product should not be administered to a nursing mother.
Caution Required Dosage selection must be cautious for older adults and for patients with renal disease, congestive heart failure, cardiac arrhythmias, or hypertension.

These restrictions establish that use is permissible only for adult patients who do not possess the listed absolute contraindications. Eligibility is further structured by explicit age limitations and requires a risk assessment for those with impaired organ function or pre-existing cardiac conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Stramonium's active tropane alkaloids (Hyoscyamine, Atropine, Scopolamine) have officially documented interaction patterns primarily through pharmacodynamic reinforcement and altered pharmacokinetics due to changes in gastrointestinal motility.

Pharmacodynamic Interactions

Co-administration with medicines that possess anticholinergic properties may lead to additive adverse effects, as officially stated in regulatory documents. This interaction pattern applies to agents such as Tricyclic Antidepressants, Monoamine Oxidase (MAO) Inhibitors, Phenothiazines, Amantadine, and other Antimuscarinics. Furthermore, combining the medicine with CNS Depressants (including sedatives or opioids) may potentiate Central Nervous System (CNS) adverse reactions such as increased drowsiness and disorientation. Alcohol may also increase the risk of CNS side effects.

Pharmacokinetic and Timing Constraints

The presence of Stramonium components may decrease the rate of absorption of co-administered oral medications due to a reduction in gastrointestinal propulsive motility. Official labeling mandates that Antacids must be administered separately from the medicine to prevent interference with absorption. Additionally, co-administration with oral forms of Potassium Chloride is officially not recommended.

Population-Specific Notes

The regulatory profile notes that the risk of toxic reactions may be greater in patients with impaired renal function. Geriatric patients and those with impaired hepatic function may also have an increased susceptibility to CNS adverse reactions during concomitant treatment.

Mechanism of Action

The active ingredients in Stramonium, the tropane alkaloids (Hyoscyamine, Atropine, and Scopolamine), function exclusively by targeting the involuntary signaling pathways of the autonomic nervous system. Their collective mechanism centers on the competitive blockade of specific receptors, leading to predictable physiological inhibitory consequences.


The Molecular Switch: Blocking Muscarinic Receptors

The primary mechanism involves competitive antagonism at Muscarinic Acetylcholine Receptors ( mAChRs). The alkaloids physically occupy the receptor sites, thereby preventing the natural neurotransmitter Acetylcholine (ACh) from binding and initiating the signal for contraction or secretion. This action directly suppresses the transmission within the Parasympathetic Nervous System (PNS).


The Physiological Outcome: Smooth Muscle Relaxation and Inhibition of Secretion

By inhibiting the mAChR-mediated signaling that commands contraction, the alkaloids produce relaxation of smooth muscle tone. Simultaneously, this antagonism halts the signaling pathways that drive exocrine gland activity, resulting in the inhibition of exocrine secretion. The blend of alkaloids ensures both comprehensive peripheral effects and a degree of central modulation.

Dosage and Administration Information

How to Use Stramonium

Instructions for the administration of the active tropane alkaloids in Stramonium (e.g., Hyoscyamine) are standardized, governing dosage, timing, and route of intake.


Administration Scope

Category Instruction
Route of administration Available forms include Oral (tablet, liquid), Sublingual (under the tongue), and Parenteral (Intravenous, Intramuscular, or Subcutaneous injection) administration.
Dosing schedule Immediate-Release (IR): Standard adult dose is generally 0.125 mg to 0.25 mg per dose, with a strict maximum of 1.5 mg in a 24-hour period. Extended-Release (ER): The dose is typically 0.375 mg per unit.
Timing in relation to meals (if applicable) Immediate-release oral forms are instructed to be administered before meals.
Age-group administration rules Pediatric patients (2 to under 12 years) have a lower maximum daily dose of 0.75 mg. Some specific formulations are not used in children under 12.
Missed-dose rules If a dose is missed, it should be taken as soon as remembered; if it is almost time for the next dose, the missed dose is skipped to avoid taking a double dose.
Special procedural conditions IR tablets may be chewed or taken sublingually. ER tablets, designed for controlled release, must be swallowed whole and not split, chewed, or crushed.

Instruction Classifications (High-Level)

Classification Pattern
Administration method type Oral/Sublingual (for daily use); Parenteral (for acute or specialized procedural use).
Frequency pattern The use is classified as As-Needed (PRN) for IR forms (typically every four hours), or Scheduled Daily for ER forms (typically twice daily).
Basis of Use Standardized clinical guidelines.
Use-context constraints The schedule is constrained by the dosage form: IR forms address acute episodic need, while ER forms provide a sustained, scheduled maintenance use pattern.

Resulting Procedural Structure

Step sequence:

  • Adhere to the prescribed route and form integrity, ensuring ER tablets are taken whole.
  • Administer the dose, ensuring it does not exceed the strict daily maximum, especially for the IR formulation.
  • Follow the before meals timing constraint for immediate-release oral forms.
  • Use the scaled-down pediatric dose when administering to children aged 2 to 12 years.

Connection to the overall use protocol: The instructions establish a structured protocol centered on low-dose administration and form integrity, differentiating use into either a short-term, as-needed (PRN) schedule or a fixed, twice-daily maintenance regimen. This framework strictly controls the amount of active ingredient taken and dictates the proper timing relative to meals to ensure consistent administration.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Stramonium (derived from the plant Datura stramonium) is a source of tropane alkaloids, including atropine and scopolamine. Due to the potent toxicity and unpredictable effects of these compounds, modern, large-scale randomized controlled trials (RCTs) supporting the use of the raw plant or its unstandardized extracts for therapeutic purposes are scarce or non-existent.


Early Phase Research and Traditional Use

Initial laboratory research has focused on isolating and characterizing the biological activities of the plant's various extracts, including antioxidant, antimicrobial, and anti-inflammatory properties observed in non-human studies. Historically, various preparations of the plant have been used in traditional medicine for respiratory conditions, such as asthma, due to the bronchodilating activity of its anticholinergic alkaloids.


Safety and Toxicity Data

The majority of available clinical data regarding Stramonium in modern medical literature are case reports and case series documenting toxicity and accidental or intentional poisoning. Ingestion of the plant material can lead to anticholinergic syndrome, characterized by a range of severe symptoms including visual hallucinations, confusion, delirium, mydriasis (dilated pupils), dry mouth, and tachycardia. The severity of poisoning depends on the amount consumed and individual susceptibility, and often necessitates immediate hospital care due to the risks of central nervous system depression or cardiovascular events.

Frequently Asked Questions (FAQ)

Common questions about Stramonium (FAQ)

Q: Is it okay to drive or operate machinery while taking Stramonium?

Official labeling advises that hazardous activities should be avoided until an individual understands how the medicine affects them. This is because the drug's anticholinergic effects can potentially cause drowsiness, dizziness, or blurred vision, which can potentially impair functions required for operating machinery.


Q: How long do the effects of Stramonium typically last?

The duration of effect depends on the specific form of the medicine used. For standard oral forms, the effect generally lasts up to approximately four hours. If an extended-release (ER) preparation is used, the action is prolonged and may last for up to approximately twelve hours.


Q: Is Stramonium prescription-only or available over the counter in most countries?

The purified active components of Stramonium, such as Hyoscyamine, are officially classified by regulatory bodies as a legend drug. This classification means the medicine is legally available only by prescription from a licensed healthcare provider.


Q: What is the official risk classification for Stramonium in specific populations?

Official labeling identifies key risk factors for specific populations. The medicine is assigned the US FDA Pregnancy Category C, meaning its use during pregnancy is conditional. Furthermore, older adults and children under 12 are noted as being more sensitive to its potential toxic effects.


Q: What is the typical duration of treatment with Stramonium as described in guidelines?

Official regulatory guidance describes use as either as-needed (PRN) for acute symptoms or as scheduled maintenance for chronic conditions. However, regulatory guidance indicates a preference for short-term use patterns to mitigate the risk of strong anticholinergic side effects.


Q: Can Stramonium be used for pain relief?

While the drug is not generally classified as a pain reliever, its primary function is to relieve spasms. This antispasmodic action is sometimes utilized as an adjunctive treatment for cramping pain associated with conditions such as kidney stones or gallstones.


Q: What are the official warnings listed for Stramonium use in the elderly?

Official regulatory documents specifically warn that older adults may have an increased sensitivity to the side effects. This includes a higher risk of central nervous system effects such as confusion and drowsiness, and a higher risk of difficulty with urination, which may increase the risk of falls.


Q: Can pregnant or breastfeeding individuals use Stramonium?

Use during pregnancy is conditional (Category C) and is only administered if clearly needed. As the active components are known to pass into breast milk, official documents state its use is not recommended for a nursing mother.


Q: Is Stramonium considered a controlled substance by regulatory bodies?

The pure active component (Hyoscyamine) is typically not scheduled as a controlled substance in the US. However, combination medicines containing Hyoscyamine alongside other sedative or controlled ingredients may fall under regulatory scheduling.


Q: What is the risk if too much Stramonium is taken?

Taking too much of the medicine can lead to toxicity (overdose). Symptoms of toxicity may include severe confusion, hallucinations, anxiety, dizziness, blurred vision, and a rapid heartbeat. If these signs occur, emergency medical services should be contacted.


Q: Does Stramonium affect sleep patterns?

Yes, regulatory documents list potential adverse reactions related to the central nervous system. Insomnia, or trouble sleeping, is a known potential side effect of the medicine.


Q: Are there any known interactions between Stramonium and herbal supplements?

Official labeling primarily details interactions with other prescribed and over-the-counter medicines. Patients should inform their doctor about all products, including herbal supplements, as some may possess anticholinergic properties that could reinforce the side effects of Stramonium.


Q: What are the signs of a serious allergic reaction to Stramonium?

While rare, a serious allergic reaction includes signs such as difficulty breathing, the development of hives or a rash, swelling of the face, tongue, or throat, or severe dizziness. These are serious signs that necessitate contacting emergency services.


Q: Is Stramonium used for anxiety or mood disorders?

No, official indications for this medicine are related to treating physical conditions involving spasms and hypermotility in the gastrointestinal or genitourinary tracts. It is not indicated for the treatment of anxiety or other mood disorders.


Q: What happens when Stramonium is stopped abruptly?

In formulations combined with other sedative ingredients, abrupt cessation may cause withdrawal symptoms. Patients who have used the medication for a significant duration are advised to consult with their healthcare provider to discuss discontinuing the medicine.


Q: Does official labeling mention any liver or kidney precautions for Stramonium?

Yes, official documents advise using the medicine with caution in patients who have pre-existing hepatic (liver) or renal (kidney) disease. These conditions can alter how the drug is processed by the body and may increase the risk of adverse effects.


Q: Is Stramonium related to any plant or herb?

Yes, Stramonium is the traditional term for the crude drug derived from the dried leaf of the thorn-apple plant, Datura stramonium L., which is a poisonous herb commonly known as jimsonweed.


Q: What kind of patient monitoring is mentioned in official prescribing information for Stramonium?

Official information indicates that screening for certain existing conditions (such as glaucoma) is necessary before use. Ongoing monitoring is primarily focused on observing the patient for and managing potential anticholinergic side effects and signs of toxicity.


Q: Are there any known interactions between Stramonium and alcohol?

Official regulatory documents confirm an interaction between this medicine and alcohol. Drinking alcohol while using the medicine can increase the risk of central nervous system side effects, such as excessive drowsiness and dizziness.


Q: Is Stramonium known to interact with birth control pills?

Yes, regulatory sources indicate that this medicine can potentially affect the absorption or metabolism of hormone-based contraceptives. It may cause birth control pills and other similar methods to be less effective at preventing pregnancy.


Q: Are there different strengths of Stramonium available?

Yes, the purified active component (Hyoscyamine) is manufactured in different strengths to meet varying clinical needs. This includes lower doses for immediate-release forms and higher doses for controlled or extended-release forms.


Q: Does Stramonium interact with common psychiatric medications (e.g., SSRIs)?

The medicine can produce additive anticholinergic effects when combined with many other psychiatric medications. Additionally, co-administration with any Central Nervous System (CNS) depressants may increase side effects like sedation and confusion.


Q: What is the difference between Stramonium and atropine?

Stramonium refers to the plant or crude drug material itself. Atropine is one of the specific, purified, highly potent tropane alkaloids—a chemical component—that is naturally found within Stramonium and contributes to its pharmacological effects.


Q: Do official sources indicate Stramonium is less effective over time (tolerance)?

Official product information suggests that when the medicine is used for a prolonged duration, it may not work as effectively as it did initially. This indicates the potential for the body to develop tolerance, which may necessitate a change in the regimen.

How should Stramonium be stored and disposed of?

How to Store and Dispose of Stramonium

Official regulatory documents define strict requirements for storing and disposing of medicines containing Stramonium's active components to ensure product quality and household safety.

Storage Requirements

Condition Regulatory Mandate
Temperature Must be stored at Controlled Room Temperature (20°C to 25°C or 68°F to 77°F).
Protection Requires storage in a tight, light-resistant container to protect it from light and excessive moisture.
Child Safety Keep out of the reach and sight of children at all times.

Disposal Instructions

Unused or expired medication must be disposed of according to local, state, or federal laws, as directed by a healthcare professional or pharmacist. The product should not be discarded into standard household trash or wastewater unless specifically instructed by regulatory guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Stramonium found in:

A-Z Index: